TherapeuticsMD Inc (TXMD) Price Prediction & ForecastTXMDTherapeuticsMD Inc

Alphio's TXMD stock price prediction model matches the current TherapeuticsMD Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.74 (+2.29%). The 1-week path is $1.82 (+7.12%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

TherapeuticsMD Inc (TXMD) is currently trading at $1.70, which is significantly below its 52-week high of $2.95, indicating potential upside. However, the RSI is at 35.87, suggesting the stock is in oversold territory, but the recent 5-day change is down 5.56%, indicating negative momentum. The forward P/E ratio is a very low 2.33, suggesting the stock may be undervalued, but the company has a history of inconsistent earnings, with a net loss of $619,000 in Q4 2025. The main risk is the company's negative net income trend, with a net loss of $619,000 in the last quarter reported, which could impact future performance and investor confidence.

TherapeuticsMD Inc (TXMD) last closed at $1.7, losing -0.58%. These facts feed the 1-day and 1-week TXMD price prediction above.